Back to News

Tag: BioNTech

Articles

AI Day

BioNTech Highlights AI Capabilities and R&D Use Cases at Inaugural AI Day

Posted on

Provides updates on BioNTech’s strategy to scale and deploy AI-capabilities across the immunotherapy pipeline  Highlights InstaDeep’s new near exascale supercomputer, Kyber, with the aim of enabling BioNTech to compute at scale  Unveils novel AI Bayesian Flow Network (“BFN”) models for protein sequence generation  Highlights progress in deploying AI across BioNTech’s immunotherapy pipeline, including in immunohistochemistry, DNA/RNA sequencing, proteomics, protein design, and lab functional validation  LONDON, United Kingdom, October… Read more »

BioNTech to Acquire InstaDeep to Strengthen Pioneering Position in the Field of AI-powered Drug Discovery, Design and Development

Posted on

Acquisition to enable creation of a fully integrated, enterprise-wide capability to discover, design and develop next-generation immunotherapies at scale by leveraging artificial intelligence and machine learning technologies across BioNTech’s therapeutic platforms and operations Builds on multi-year strategic collaboration between BioNTech and InstaDeep which included the formation of an AI Innovation Lab in 2020 and completion… Read more »

InstaDeep Raises $100M to Scale Decision-Making AI Products that Solve Real-World Problems

InstaDeep Raises $100M to Scale Decision-Making AI Products that Solve Real-World Problems

Posted on

Series B led by Alpha Intelligence Capital; BioNTech and Deutsche Bahn among Investors  LONDON (JAN 25, 2022) – InstaDeep, a leader in advanced AI decision-making systems for solving real-world problems, announced today it has raised $100M and closed a Series B round led by Alpha Intelligence Capital together with CDIB.  Investors in the round include… Read more »

BioNTech and InstaDeep Developed and Successfully Tested Early Warning System to Detect Potential High-Risk SARS-CoV-2 Variants

Posted on

Early Warning System combines Spike protein structural modeling with artificial intelligence (AI) to detect and monitor high-risk SARS-CoV-2 variants, identifying >90% of WHO-designated variants on average two months prior to officially receiving the designation Study introduces a new method of combining publicly available SARS-CoV-2 sequence information with predictive analytics to effectively detect and monitor potential… Read more »

BioNTech and InstaDeep Announce Strategic Collaboration and Form AI Innovation Lab to Develop Novel Immunotherapies

Posted on

Long-term collaboration underpins BioNTech’s strategy to leverage Artificial Intelligence (AI) and Machine Learning (ML) technologies to support the discovery and development of novel immunotherapies based on InstaDeep’s DeepChainTM technology platform BioNTech and InstaDeep to establish a joint AI Innovation Lab to advance a portfolio of enterprise-wide digital initiatives in the areas of drug discovery and design,… Read more »